Bacillary Dysentery

  • Herbert L. DuPont
  • Larry K. Pickering
Part of the Current Topics in Infectious Disease book series (CTID)


Bacillary dysentery is a common diarrheal syndrome generally caused by one of 32 serotypes of Shigella and less commonly by invasive strains of E. coli. Many cases of dysentery remain undiagnosed after laboratory examination. Camp ylobacter recently has been shown to produce a dysentery syndrome, and other causes will be identified in future studies. The term “dysentery” was used by Hippocrates to indicate a condition characterized by the frequent passage of stools containing blood and mucus and accompanied by straining and painful defecation. At the end of the 19th century, the causative agents were identified, and the two forms of dysentery, bacillary and amebic, were distinguished. Much of the dysentery described in older writings is felt to be bacillary (shigellosis) in origin due to rarity of liver involvement. Outbreaks of bacillary dysentery through the first World War were as important in deciding the outcome of most military campaigns as war-related injuries. The most characteristic clinical picture of shigellosis is dysentery (bloody, mucoid stools) in which the passage of numerous small-volume stools is associated with variable degrees of fever, systemic toxicity, fecal urgency, and tenesmus. The causative agent may produce less striking diarrhea without fever.


Cynomolgus Monkey Watery Diarrhea Shigella Flexneri Acute Diarrhea Oxolinic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Morris, G. K., Koehler, J. A., Gangarosa, E. J., et al. Comparison of media for direct isolation and transport of shigellae from fecal specimens. Appl. Microbiol. 19:434–437, 1970.PubMedGoogle Scholar
  2. 2.
    Thomason, B. M., Cowart, G. S., Cherry, W. B., Current status of immunofluorescence techniques for rapid detection of shigellae in fecal specimens. App. Microbiol. 13:605–613,1965.Google Scholar
  3. 3.
    Mata, J., Gangarosa, E. J., Caceres, A., et al. Epidemic Shiga bacillus dysentery in Central America: I. Etiologic investigations in Guatemala, 1969. J. Infect. Dis. 122:170–180,1970.PubMedCrossRefGoogle Scholar
  4. 4.
    Rahaman, M. M., Huq, I., Dey, C. R. Superiority of MacConkey’s agar over Salmonella-shigella agar isolation of Shigella dysenteriae type 1. J. Infect. Dis. 131:700–703, 1975.PubMedCrossRefGoogle Scholar
  5. 5.
    Edwards, P. R., Ewing, W. H. Identification of Enterobacteriaceae,3rd ed. Bergess, Minneapolis, 1972.Google Scholar
  6. 6.
    LaBrec, E. H., Schneider, H., Magnani, T. J., Jr. Epithelial cell penetration as an essential step in the pathogenesis of bacillary dysentery. J. Bacteriol. 88:1503–1518, 1964.PubMedGoogle Scholar
  7. 7.
    Formal, S. B., Gemski, P., Jr., Baron, L. S., et al. A chromosomal locus which controls the ability of Shigella fiexneri to evoke keratoconjunctivitis. Infect. Immun. 3:73–79, 1971.PubMedGoogle Scholar
  8. 8.
    Takeuchi, A., Sprinz, H., LaBrec, E. H., et al. Experimental bacillary dysentery: An electron microscopic study of the response of the intestinal mucosa to bacterial invasion. Am. J. Pathol. 47:1011–1044, 1965.PubMedGoogle Scholar
  9. 9.
    Shiga, K. The trend of prevention, therapy and epidemiology of dysentery since the discovery of its causative organism. N. Eng. J. Med. 215:1205–1211, 1936.CrossRefGoogle Scholar
  10. 10.
    Takeuchi, A., Formal, S. B., Sprinz, H. Experimental acute colitis in the rhesus monkey following peroral infection with Shigella fiexneri. Am. J. Pathol . 52:503–529, 1968.Google Scholar
  11. 11.
    Ogawa, H., Nakamura, A., Nakaya, R. Cinemicrographic study of tissue cell cultures infected with Shigella fiexneri. Jpn. J. Med. Sci. Biol. 21:259–273, 1968.Google Scholar
  12. 12.
    Takaska, M., Honjo, S., Fujiwara, T., et al. Shigellosis in cynomolgus monkeys (Ma-caca irus): VI. The inoculation with various doses of Shigella fiexneri 2a into cecal lumen. Jpn. J. Med. Sci. Biol. 21:275–281, 1968.Google Scholar
  13. 13.
    Evans, D. J., Jr., Evans, D. G. Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis. Infect. Immun. 16:604–609, 1977.PubMedGoogle Scholar
  14. 14.
    Rout, W. R., Formal, S. B., Giannella, R. A., et al. Pathophysiology of Shigella diarrhea in the rhesus monkey: Intestinal transport, morphological, and bacteriological studies. Gastroenterology 68:270–278, 1975.PubMedGoogle Scholar
  15. 15.
    Kinsey, M. D., Formal, S. B., Dammin, G. J., et al. Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a. Infect. Immun. 14:368–371,1976.PubMedGoogle Scholar
  16. 16.
    McIver, J., Grady, G. F., Keusch, G. T., Production and characterization of exotoxin(s) of Shigella dysenteriae type 1. J. Infect. Dis. 131:559–566, 1975.PubMedCrossRefGoogle Scholar
  17. 17.
    Keusch, G. T., Jacewicz, M. The pathogenesis of shigella diarrhea: VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans. J. Infect. Dis. 135:552–556, 1977.PubMedCrossRefGoogle Scholar
  18. 18.
    O’Brien, A. D., Thompson, M. R., Gemski, P., et al. Biological properties of Shigella flexneri 2a toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect. Immun. 15:796–798, 1977.PubMedGoogle Scholar
  19. 19.
    DuPont, H. L., Hornick, R. B., Dawkins, A. T., et al. The response of man to virulent Shigella flexneri 2a. J. Infect. Dis. 119:296–299, 1969.PubMedCrossRefGoogle Scholar
  20. 20.
    Yee, R. B., Buffenmyer, C. L. Infection of cultured mouse macrophages with Shigella flexneri, Infect. Immun. 1:459–463, 1970.PubMedGoogle Scholar
  21. 21.
    DuPont, H. L., Gangarosa, E. J., Relier, L. B., et al. Shigellosis in custodial institutions. Am. J. Epidemiol. 92:172–179, 1970.PubMedGoogle Scholar
  22. 22.
    Levine, M. M., DuPont, H. L., Khodabandelou, M., et al. Long-term Shigella-carrier state. N. Engl. J. Med. 288:1169–1171, 1973.PubMedCrossRefGoogle Scholar
  23. 23.
    Hardy, A.V., Watt, J. Studies of the acute diarrheal diseases: XVIII. Epidemiology. Public Health Rep. 63:363–378, 1948.PubMedCrossRefGoogle Scholar
  24. 24.
    Tjoa, W. S., DuPont, H. L., Sullivan, P., et al. Location of food consumption and travelers’ diarrhea. Am. J. Epidemiol. 106:61–66, 1977.PubMedGoogle Scholar
  25. 25.
    Pickering, L. K., DuPont, H. L., Evans, D. G., et al. Isolation of enteric pathogens from asymptomatic students from the United States and Latin America. J. Infect. Dis 135:1003–1005, 1977.PubMedCrossRefGoogle Scholar
  26. 26.
    Haltalin, K. C. Neonatal shigellosis: Reports of 16 cases and review of the literature. Am. J. Dis. Child. 114:603–611, 1967.PubMedGoogle Scholar
  27. 27.
    Mata, L. J., Urrutia, J. J., Garcia, B., et al. Shigella infection in breast-fed Guatemalan Indian neonates. Am. J. Dis. Child. 117:142–146, 1969.PubMedGoogle Scholar
  28. 28.
    Rogers, L. Bacillary dysentery. In Dysenteries: Their Differentiation and Treatment. Oxford University Press, Oxford, 1913, p. 268.Google Scholar
  29. 29.
    Weissman, J. B., Schmerler, A., Weiler, P., et al. The role of preschool children and day-care centers in the spread of shigellosis in urban communities. J. Pediatr. 84:797–802,1974.PubMedCrossRefGoogle Scholar
  30. 30.
    Weissman, J. B., Gangarosa, E. J., Schmerler, A., et al. Shigellosis in day-care centers. Lancet 1:88–90, 1975.PubMedCrossRefGoogle Scholar
  31. 31.
    DuPont, H. L., Hornick, R. B. Clinical approach to infectious diarrheas. Medicine (Baltimore) 52:265–270, 1973.Google Scholar
  32. 32.
    Davison, W. C. A bacteriological and clinical consideration of bacillary dysentery in adults and children. Medicine 1:389–510, 1922.CrossRefGoogle Scholar
  33. 33.
    Felsen, J. Bacillary Dysentery,Colitis and Enteritis. W. B. Saunders, Philadelphia, 1945.Google Scholar
  34. 34.
    Watt, J., Lindsay, D. R. Diarrheal disease control studies: I. Effect of fly control in a high morbidity area. Public Health Rep. 63:1319–1334, 1948.PubMedCrossRefGoogle Scholar
  35. 35.
    Rosenberg, M. L., Hazlet, K. K., Schaefer, J., et al. Shigellosis from swimming. J. Am. Med. Assoc. 236:1849–1852, 1976.CrossRefGoogle Scholar
  36. 36.
    Hutchinson, R. I. Some observations on the method of spread of sonne dysentery. Month. Bull. Minist. Health 15:110–118, 1956.Google Scholar
  37. 37.
    Gerba, C. P., Wallis, C., Melnick, J. L. Microbiological hazards of household toilets: Droplet production at the fate of residual organisms. Appl. Microbiol. 30:229–237, 1975.PubMedGoogle Scholar
  38. 38.
    Gettings, H. S. Bacillary dysentery. Trans. Soc. Trop. Med. Hyg. (London) 8:111–136 1914–1915.CrossRefGoogle Scholar
  39. 39.
    Kostrzewski, J., Stypulkowska-Misiurewicz, H. Changes in the epidemiology of dysentery in Poland and the situation in Europe. Arch. Immunol. Ther. Exp. 16:429–451, 1968.Google Scholar
  40. 40.
    Marier, R., Wells, J. G., Swanson, R. C., et al. An outbreak of enteropathogenic Escherichia coli foodborne disease traced to imported French cheese. Lancet 2:1376–1378,1973.CrossRefGoogle Scholar
  41. 41.
    Haltalin, K. C., Nelson, J. D. Coliform septicemia complicating shigellosis in children. J. Am. Med. Assoc. 192:441–443, 1965.CrossRefGoogle Scholar
  42. 42.
    Henson, M. Bacillary dysentery with bacteremia. Am. J. Med. Technol. 22:179–183, 1956.Google Scholar
  43. 43.
    Chesney, R., Kaplan, B. S. Hemolytic-uremic syndrome with shigellosis (letter). J. Pediatr. 84:312–313, 1974.PubMedCrossRefGoogle Scholar
  44. 44.
    Barrett-Connor, E., Conner, J. D. Extra-intestinal manifestations of shigellosis. Am. J. Gastroenterol. 52:234–245, 1970.Google Scholar
  45. 45.
    Stern, M. S., Gitnick, G. L. Shigella hepatitis. J. Am. Med. Assoc. 235:2628, 1976.CrossRefGoogle Scholar
  46. 46.
    Gregory, J. E., Starr, S. P., Omdal, C. Wound infection with Shigella fiexneri (letter). J. Infect. Dis. 129:602–604, 1974.PubMedCrossRefGoogle Scholar
  47. 47.
    Calin, A., Fries, J. F. An “experimental” epidemic of Reiter’s syndrome revisited: Follow-up evidence on genetic and environmental factors. Ann. Intern. Med. 84:564–566,1976.PubMedGoogle Scholar
  48. 48.
    Evans, H. E., Sampath, A. C., Douglass, F., et al. Shigella bacteremia in a patient with sickle cell anemia. Am. J. Dis. Child. 123:238–239,1972.PubMedGoogle Scholar
  49. 49.
    Harris, J. C., DuPont, H. L., Hornick, R. B. Fecal leukocytes in diarrheal illness. Ann. Intern. Med. 76:697–703, 1972.PubMedGoogle Scholar
  50. 50.
    Pickering, L. K., DuPont, H. L., Olarte, J., et al. Fecal leukocytes in enteric infections. Am. J. Clin. Pathol. 68:562–565, 1977.PubMedGoogle Scholar
  51. 51.
    Sereny, B. Experimental shigella keratoconjunctivitis: A preliminary report. Acta Microbiol. Acad. Sci. Hung. 2:293–296, 1955.Google Scholar
  52. 52.
    Caceres, A., Mata, L. J. Serologic response of patients with Shiga dysentery. J. Infect. Dis. 129:439–443, 1974.PubMedCrossRefGoogle Scholar
  53. 53.
    Honjo, S., Takasaka, M., Fukiwara, T., et al. Shigellosis in cynomolgus monkeys (Macaca irus): V. Resistance acquired by the repetition of experimental oral infection with Shigella flexneri 2a and fluctuation of serum agglutinin titer. Jpn. J. Med. Sci. Biol. 20:341–348, 1967.PubMedGoogle Scholar
  54. 54.
    DuPont, H. L., Hornick, R., B., Snyder, M. J.,et al. Immunity in shigellosis: II. Protection induced by oral live vaccine or primary infection. J. Infect. Dis.125:12–16, 1972.Google Scholar
  55. 55.
    Cruickshank, R. Acquired immunity: Bacterial infections. Mod. Trends Immunol. 1:107–109,1963.Google Scholar
  56. 56.
    Hardy, A. V., Watt, J. The acute diarrheal diseases. J. Am. Med. Assoc. 124:1173–1179, 1944.CrossRefGoogle Scholar
  57. 57.
    DuPont, H. L., Gangarosa, E. J., Relier, L. B., et al. Shigellosis in custodial institutions. Am. J. Epidemiol. 92:172–179, 1970.PubMedGoogle Scholar
  58. 58.
    Besredka, A. Local Immunization. Williams & Wilkins, Baltimore, 1927.Google Scholar
  59. 59.
    Davies, A. An investigation into the serological properties of dysentery stools. Lancet 2:1009–1012, 1922.CrossRefGoogle Scholar
  60. 60.
    Burrows, W., Elliott, M. E., Havens, I. Studies on immunity to Asiatic cholera: IV. The excretion of coproantibody in experimental enteric cholera in the guinea pig. J. Infect. Dis. 81:261–281, 1947.PubMedCrossRefGoogle Scholar
  61. 61.
    Burrows, W., Havens, I. Studies on immunity to Asiatic cholera: V. The absorption of immune globulin from the bowel and its excretion in the urine and feces of experimental animals and human volunteers. J. Infect. Dis. 82:231–250, 1948.PubMedCrossRefGoogle Scholar
  62. 62.
    Gordon, R. S., Bennet, I. L., Jr., Barnes, L. A. Field trial of Shigella fiexneri III vaccine: III. Coproantibody studies. J. Infect. Dis. 86:197–201, 1950.PubMedCrossRefGoogle Scholar
  63. 63.
    Freter, R., De, S. P., Mondai, A., et al. Coproantibody and serum antibody in cholera patients. J. Infect. Dis. 115:83–87, 1965.PubMedCrossRefGoogle Scholar
  64. 64.
    Formal, S. B., Maenza, R. M., Austin, S., et al. Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc. Soc. Exp. Biol. Med. 125:347–349, 1987.Google Scholar
  65. 65.
    Honjo, S., Takasaka, M., Imaizumi, K., et al. Oral challenge with Shigella fiexneri 2a in cynomolgus monkeys having extremely high titer of serum agglutinin. Jpn. J. Med. Sci. Biol. 21:283–287, 1968.PubMedGoogle Scholar
  66. 66.
    Hardy, A. V., DeCapito, T., Halbert, S. P. Studies of acute diarrheal diseases: XIX. Immunization in shigellosis. Public Health Rep. 63:685–688, 1948.PubMedCrossRefGoogle Scholar
  67. 67.
    Higgins, A. R., Floyd, T. M., Kader, M. A. Studies in shigellosis: III. A controlled evaluation of a monovalent shigella vaccine in a highly endemic environment. Am. J. Trop. Med. Hyg. 4:281–288, 1955.PubMedGoogle Scholar
  68. 68.
    Formal, S. B., LaBrac, E. H., Palmer, A., et al. Protection of monkeys against experimental shigellosis with attenuated vaccines. J. Bacteriol. 90:63–68, 1965.PubMedGoogle Scholar
  69. 69.
    Formal, S. B., Kent, T. H., Austin, S., et al. Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella fiexneri. J. Bacteriol. 91:2368–2376, 1966.PubMedGoogle Scholar
  70. 70.
    Formal, S. B., Kent, T. H., May, H. C., et al. Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J. Bacteriol. 92:17–22, 1966.PubMedGoogle Scholar
  71. 71.
    Mel, D. M., Arsié, B. L., Nickolié, B. D., et al. Studies on vaccination against bacillary dysentery: 4. Oral immunization with live monotypic and combined vaccines, Bull. W. H. O. 39:375–380, 1968.PubMedGoogle Scholar
  72. 72.
    Mel, D. M., Gangarosa, E. J., Radovanovic, M. L., et al. Studies on vaccination against bacillary dysentery: 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull. W.H.O. 45:457–464, 1971.PubMedGoogle Scholar
  73. 73.
    Farrar, W. E., Jr., Eidson, M. Antibiotic resistance in Shigella mediated by R factors. J. Infect. Dis. 123:477–484, 1971.PubMedCrossRefGoogle Scholar
  74. 74.
    Weissman, J. B., Gangarosa, E. J., DuPont, H. L., et al. Shigellosis: To treat or not to treat? J. Am. Med. Assoc. 229:1215–1216, 1974.CrossRefGoogle Scholar
  75. 75.
    Cheever, F. S. Treatment of shigellosis with antibiotics. Ann. N.Y. Acad. Sci. 55:1063–1069,1952.CrossRefGoogle Scholar
  76. 76.
    Aserkoff, B., Bennett, J. V. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N. Engl. J. Med. 281:636–6640, 1969.PubMedCrossRefGoogle Scholar
  77. 77.
    Byers, P. A., DuPont, H. L., Goldschmidt, M. C. Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974. Antimicrob. Agents Chemother. 9:288291, 1976.Google Scholar
  78. 78.
    Haltalin, K. C., Nelson, J. D., Hinton, L. V., et al. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. J. Pediatr. 72:708–720, 1968.PubMedCrossRefGoogle Scholar
  79. 79.
    Haltalin, K. C., Nelson, J. D., Kusmiesz, H. T., et al. Comparison of intramuscular and oral ampicillin therapy for shigellosis. J. Pediatr. 73:617–622, 1968.PubMedCrossRefGoogle Scholar
  80. 80.
    Haltalin, K. C., Nelson, J. D. Failure of furazolidone therapy in shigellosis. Am. J. Dis. Child. 123:40–44, 1972.PubMedGoogle Scholar
  81. 81.
    Nelson, J. D., Haltalin, K. C. Comparative efficacy of cephalexin and ampicillin for shigellosis and other types of acute diarrhea in infants and children. Antimicrob. Agents Chemother. 7:415–420, 1975.Google Scholar
  82. 82.
    Nelson, J. D., Haltalin, K. C. Amoxicillin less effective than ampicillin against Shigella in vitro and in vivo: Relationship of efficacy to activity in serum. J. Infect. Dis. 129: S222–S227, 1974.PubMedCrossRefGoogle Scholar
  83. 83.
    Nelson, J. D., Kusmiesz, H., Jackson, L. H., et al. Trimethoprim-sulfamethoxazole therapy for shigellosis. J. Am. Med. Assoc. 235:1239–1243, 1976.CrossRefGoogle Scholar
  84. 84.
    Garfinkel, B. T., Martin, G. M., Watt, J., et al. Antibiotics in acute bacillary dysentery: Observations in 1408 cases with positive cultures. J. Am. Med. Assoc. 151:1157–1159, 1953.Google Scholar
  85. 85.
    Lionel, N. D., Abeyasekera, F. J., Samarasinghe, H. G., et al. A comparison of a single dose and a five-day course of tetracylcine therapy in bacillary dysentery. J. Trop. Med. Hyg. 72:170–172, 1969.PubMedGoogle Scholar
  86. 86.
    Pickering, L. K., DuPont, H. L., Olarte, J. Single-dose tetracycline therapy for shigellosis in adults. J. Am. Med. Assoc. 239:853–854, 1978.CrossRefGoogle Scholar
  87. 87.
    DuPont, H. L., Hornick, R. B., Snyder, M. J. Unpublished data.Google Scholar
  88. 88.
    Atlas, E., Clark, H., Silverblatt, F., et al. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Ann. Intern. Med. 70:713–721, 1969.PubMedGoogle Scholar
  89. 89.
    DuPont, H. L., Hornick, R. B. Adverse effect of Lomotil therapy in shigellosis. J. Am. Med. Assoc. 226:1525–1528, 1973.CrossRefGoogle Scholar
  90. 90.
    Pittman, F. E. Adverse effects of Lomotil (letter). Gastroenterology 67:408–410, 1974.PubMedGoogle Scholar
  91. 91.
    Toxic megacolon—Medical Staff Conference, University of California, San Francisco. West. J. Med. 124:122–127, 1976.Google Scholar
  92. 92.
    Brown, J. W. Toxic megacolon associated with loperamide therapy. J. Am. Med. Assoc. 241:501–502, 1979.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1980

Authors and Affiliations

  • Herbert L. DuPont
    • 1
  • Larry K. Pickering
    • 2
  1. 1.Program in Infectious Diseases and Clinical MicrobiologyThe University of Texas Health Science Center Medical SchoolHoustonUSA
  2. 2.Pediatric Infectious Diseases Program in Infectious Diseases and Clinical MicrobiologyThe University of Texas Health Science Center Medical SchoolHoustonUSA

Personalised recommendations